InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,841.47
(
0.00%
)
US TECH 100
19,775.60
(
0.64%
)
Dow Jones
43,239.05
(
0.00%
)
Brent Oil
73.89
(
-0.36%
)
Bitcoin
67,669.37
(
0.37%
)
Post# of 253393
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: jq1234 post# 187193

Saturday, 02/07/2015 8:14:46 PM

Saturday, February 07, 2015 8:14:46 PM

Post# of 253393
Good point. Outside of anti-virals they've been at best average. I'd be surprised if YM amounts to much, while CV Therapeutics was likely a decent but not spectacular acquisition (Ranexa sales now around $400m/year). Forget what else they bought.

I'm still waiting for them to acquire Chimerix... :)

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up